Brief: Statera Biopharma Inc - On October 12, 2022, Co Entered A Binding Memorandum Of Understanding (“MoU”) With Holobeam Technologies, Inc
18/10/2022 11:27
Oct 18 (Reuters) - Statera Biopharma Inc STAB.O :
* STATERA BIOPHARMA INC - ON OCTOBER 12, 2022, CO ENTERED A
BINDING MEMORANDUM OF UNDERSTANDING (“MOU”) WITH HOLOBEAM
TECHNOLOGIES, INC
* STATERA BIOPHARMA INC - PURSUANT TO DEAL CO TO BUY
MINORITY
INTEREST OF 25% IN HOLO FOR $25 MILLION VIA ISSUANCE OF CO’S
PREFERRED STOCK
* STATERA BIOPHARMA INC - HOLO TO PROVIDE A LICENSE TO THE
COMPANY
TO USE THEIR TECHNOLOGY PLATFORM FOR THE IDENTIFICATION AND
TREATMENT OF DISEASES
Further company coverage: STAB.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Statera Biopharma
See all news20/20 Biolabs jumps on Ebola, hantavirus testing plans
Tivic Health Systems rises after deal for late-stage immunotherapy drug
Brief: Tivic Health Acquires Exclusive Worldwide Rights To Phase III TLR5 Agonist
Brief: Statera Biopharma Inc Quarterly Loss Per Share $0.20
Brief: Statera Biopharma Inc - On October 12, 2022, Co Entered A Binding Memorandum Of Understanding (“MoU”) With Holobeam Technologies, Inc